Cargando…

Normocalcaemic hyperparathyroidism and primary hyperparathyroidism: least significant change for adjusted serum calcium

INTRODUCTION: The least significant change (LSC) is a term used in individuals in order to evaluate whether one measurement has changed significantly from the previous one. It is widely used when assessing bone mineral density (BMD) scans. To the best of our knowledge, there no such estimate availab...

Descripción completa

Detalles Bibliográficos
Autores principales: Schini, Marian, Jacques, Richard, Oakes, Eleanor, Peel, Nicola, Walsh, Jennifer S, Eastell, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707804/
https://www.ncbi.nlm.nih.gov/pubmed/33112283
http://dx.doi.org/10.1530/EJE-20-0634
_version_ 1783617432621940736
author Schini, Marian
Jacques, Richard
Oakes, Eleanor
Peel, Nicola
Walsh, Jennifer S
Eastell, Richard
author_facet Schini, Marian
Jacques, Richard
Oakes, Eleanor
Peel, Nicola
Walsh, Jennifer S
Eastell, Richard
author_sort Schini, Marian
collection PubMed
description INTRODUCTION: The least significant change (LSC) is a term used in individuals in order to evaluate whether one measurement has changed significantly from the previous one. It is widely used when assessing bone mineral density (BMD) scans. To the best of our knowledge, there no such estimate available in the literature for patients with disorders of calcium metabolism. Our aim was to provide an estimate of the least significant change for albumin-adjusted calcium in patients with normocalcaemic hyperparathyroidism (NPHPT) and primary hyperparathyroidism (PHPT). METHODS: We used the within-subject standard deviatio calculated in a population of NPHPT and PHPT patients and multiplied it by 2.77. RESULTS: The LSC for NPHPT and PHPT were found to be 0.25 and 0.24 mmol/L, respectively (1.00 and 0.96 mg/dL). In clinical practice, the value of 0.25 mmol/L could be used. DISCUSSION: The least significant change given, could be used in two ways in these patients. First, it gives a range to which values are expected. This can provide some reassurance for the patient and the physician in cases of intermittent hypercalcaemia. Moreover, it can be a marker of whether an individual has an actual significant change of his calcium after parathyroid surgery.
format Online
Article
Text
id pubmed-7707804
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-77078042020-12-07 Normocalcaemic hyperparathyroidism and primary hyperparathyroidism: least significant change for adjusted serum calcium Schini, Marian Jacques, Richard Oakes, Eleanor Peel, Nicola Walsh, Jennifer S Eastell, Richard Eur J Endocrinol Brief Report INTRODUCTION: The least significant change (LSC) is a term used in individuals in order to evaluate whether one measurement has changed significantly from the previous one. It is widely used when assessing bone mineral density (BMD) scans. To the best of our knowledge, there no such estimate available in the literature for patients with disorders of calcium metabolism. Our aim was to provide an estimate of the least significant change for albumin-adjusted calcium in patients with normocalcaemic hyperparathyroidism (NPHPT) and primary hyperparathyroidism (PHPT). METHODS: We used the within-subject standard deviatio calculated in a population of NPHPT and PHPT patients and multiplied it by 2.77. RESULTS: The LSC for NPHPT and PHPT were found to be 0.25 and 0.24 mmol/L, respectively (1.00 and 0.96 mg/dL). In clinical practice, the value of 0.25 mmol/L could be used. DISCUSSION: The least significant change given, could be used in two ways in these patients. First, it gives a range to which values are expected. This can provide some reassurance for the patient and the physician in cases of intermittent hypercalcaemia. Moreover, it can be a marker of whether an individual has an actual significant change of his calcium after parathyroid surgery. Bioscientifica Ltd 2020-10-27 /pmc/articles/PMC7707804/ /pubmed/33112283 http://dx.doi.org/10.1530/EJE-20-0634 Text en © 2021 The authors http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Brief Report
Schini, Marian
Jacques, Richard
Oakes, Eleanor
Peel, Nicola
Walsh, Jennifer S
Eastell, Richard
Normocalcaemic hyperparathyroidism and primary hyperparathyroidism: least significant change for adjusted serum calcium
title Normocalcaemic hyperparathyroidism and primary hyperparathyroidism: least significant change for adjusted serum calcium
title_full Normocalcaemic hyperparathyroidism and primary hyperparathyroidism: least significant change for adjusted serum calcium
title_fullStr Normocalcaemic hyperparathyroidism and primary hyperparathyroidism: least significant change for adjusted serum calcium
title_full_unstemmed Normocalcaemic hyperparathyroidism and primary hyperparathyroidism: least significant change for adjusted serum calcium
title_short Normocalcaemic hyperparathyroidism and primary hyperparathyroidism: least significant change for adjusted serum calcium
title_sort normocalcaemic hyperparathyroidism and primary hyperparathyroidism: least significant change for adjusted serum calcium
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707804/
https://www.ncbi.nlm.nih.gov/pubmed/33112283
http://dx.doi.org/10.1530/EJE-20-0634
work_keys_str_mv AT schinimarian normocalcaemichyperparathyroidismandprimaryhyperparathyroidismleastsignificantchangeforadjustedserumcalcium
AT jacquesrichard normocalcaemichyperparathyroidismandprimaryhyperparathyroidismleastsignificantchangeforadjustedserumcalcium
AT oakeseleanor normocalcaemichyperparathyroidismandprimaryhyperparathyroidismleastsignificantchangeforadjustedserumcalcium
AT peelnicola normocalcaemichyperparathyroidismandprimaryhyperparathyroidismleastsignificantchangeforadjustedserumcalcium
AT walshjennifers normocalcaemichyperparathyroidismandprimaryhyperparathyroidismleastsignificantchangeforadjustedserumcalcium
AT eastellrichard normocalcaemichyperparathyroidismandprimaryhyperparathyroidismleastsignificantchangeforadjustedserumcalcium